Clifton Fuller, MD

Trials

Studies that name Clifton Fuller, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:13 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06912763 · Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

  M.D. Anderson Cancer Center · recruiting · Fibrosis Syndrome, Lymphedema, Head &Amp; Neck Cancer · principal investigator
• Ph2
  NCT06494111 · Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)

  M.D. Anderson Cancer Center · recruiting · Lymphedema, Fibrosis · principal investigator
• Ph2
  NCT03224000 · Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

  M.D. Anderson Cancer Center · active not recruiting · Malignant Neoplasms of Lip Oral Cavity and Pharynx, Oropharyngeal Cancer · principal investigator
• Early Ph1
  NCT01895829 · Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI

  M.D. Anderson Cancer Center · terminated · Head and Neck Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.